Seattle Daily Star

Shares of Ion Exchange (India) Ltd jumped nearly 11% in Monday's trading session after brokerage AUM Capital initiated a 'Buy' recommendation on the water-treatment company and set a target price of Rs 468 for the next 9-12 months. The stock climbed 10.76% to an intraday high of Rs 453.50 , reflecting investor interest following the brokerage's positive assessment of the company's business diversification, order pipeline and expansion plans. AUM Capital sees strong long-term prospects for Ion Exchange, supported by its water-treatment business, robust order book and diversified product portfolio. Diversified business provides support AUM Capital highlighted Ion Exchange's presence across three key business segments—engineering, chemicals and consumer products. Engineering contributes around 61% of revenue , followed by chemicals at approximately 29% and consumer products at about 10% , according to the brokerage. The company also serves customers across a br...

Jefferies has marginally lowered its target price for JSW Infrastructure Ltd (JSW Infra) following a review of the company's FY26 annual report, while maintaining its 'Buy' recommendation on the stock. The brokerage has reduced its target to Rs 395 from Rs 400 earlier, primarily reflecting adjustments arising from the annual report. Jefferies, however, broadly retained its earnings estimates and remains positive on the company's long-term growth prospects. JSW Infra’s standalone debt rose 32% in FY26, driven by higher loans to subsidiaries for growth capex. The brokerage said JSW Infra's recently completed Rs 6,500 crore qualified institutional placement (QIP) has strengthened its ability to fund expansion projects while keeping leverage under control. The fund-raising has also removed a potential equity supply overhang, as promoter ownership has fallen below the regulatory ceiling of 75%. Why Jefferies remains positive on JSW Infra Jefferies values JSW Infra at...

The Reserve Bank of India (RBI) is stepping up its liquidity management operations as the banking system finds itself with a substantial cash surplus following unexpectedly large inflows through Foreign Currency Non-Resident (Bank), or FCNR (B), deposits. The central bank is scheduled to conduct a ₹7 lakh crore variable rate reverse repo (VRRR) auction with a 30-day tenor on Monday, September 7 , marking a significant move to absorb excess funds from the financial system. The RBI has several instruments at its disposal to regulate and manage liquidity across the financial system. The auction comes after the RBI's special FCNR (B) deposit scheme, announced in June, attracted around $127 billion —far above the market's initial expectations of $80-90 billion. The inflow was also significantly higher than the approximately $26 billion mobilised through a comparable window in 2013. The large inflows have added to domestic liquidity, increasing the need for the RBI to prevent short-t...

RPG Life Sciences is significantly scaling up its active pharmaceutical ingredients (API) business after completing two acquisitions worth a combined ₹215 crore in just five weeks. The company is now preparing for another phase of expansion, with plans to invest as much as ₹500-700 crore over the next 12 months through a mix of acquisitions and organic growth. The drugmaker is pursuing a buy-and-build strategy designed to increase manufacturing capacity, strengthen its capabilities in complex chemistry and expand its presence in international markets. RPG Life Sciences is gearing up to enter the rapidly expanding GLP-1 market, with the company targeting an October launch. The acquisitions of Actis Generics and Raghava Life Sciences have transformed the scale of RPG Life Sciences' API operations. Manufacturing capacity has increased from 110 KL to 505 KL, while the company's API customer base has more than doubled, rising from 123 to over 250. Its product portfolio has also expa...

India is considering a major weapons-integration programme for its Su-30MKI fighter fleet that could significantly expand the Indian Air Force’s ability to engage airborne targets at very long distances. The proposed upgrade involves modifying the Russian-origin Su-30MKI to carry the RVV-BD long-range air-to-air missile, a weapon associated with Russia’s R-37M missile family. The proposal is reportedly set to come before the Defence Acquisition Council (DAC), the Defence Ministry’s highest decision-making body for major defence procurement. If approved and successfully integrated, the capability would add another long-range weapon option to one of the IAF’s largest fighter fleets. The RVV-BD is Russia’s long-range air-to-air missile, with the designation linked to the R-37M family of very-long-range aerial weapons. A new long-range weapon for the Su-30MKI The RVV-BD is designed for engagements at distances far beyond those normally associated with conventional fighter-launched air-to-a...